메뉴 건너뛰기




Volumn 4, Issue 1, 2010, Pages 31-38

Development of a UGT1A1 reporter gene assay for induction studies: Correlation between reporter gene data and regulation of UGT1A1 in human hepatocytes

Author keywords

Ahr; Human hepatocytes; PXR; Reporter gene assay; Transcriptional regulation; UGT1A1 induction

Indexed keywords

3 METHYLCHLORANTHENE; ALPHA NAPHTHOFLAVONE; AROMATIC HYDROCARBON; AROMATIC HYDROCARBON RECEPTOR; BETA NAPHTHOFLAVONE; CLOTRIMAZOLE; GLUCURONOSYLTRANSFERASE 1A1; PHENOBARBITAL; RIFAMPICIN; SULFINPYRAZONE; UNCLASSIFIED DRUG; BILIRUBIN URIDINE DIPHOSPHOGLUCURONOSYL TRANSFERASE 1A1; BILIRUBIN URIDINE-DIPHOSPHOGLUCURONOSYL TRANSFERASE 1A1; DRUG; GLUCURONOSYLTRANSFERASE; LIGAND;

EID: 77953233959     PISSN: 18723128     EISSN: None     Source Type: Journal    
DOI: 10.2174/187231210790980444     Document Type: Article
Times cited : (8)

References (38)
  • 1
    • 0037819284 scopus 로고    scopus 로고
    • Pharmacogenomics of human UDP-glucuronosyl-transferase enzymes
    • Guillemette, C. Pharmacogenomics of human UDP-glucuronosyl-transferase enzymes. Pharmacogenom. J., 2003, 3(3), 136-158.
    • (2003) Pharmacogenom. J. , vol.3 , Issue.3 , pp. 136-158
    • Guillemette, C.1
  • 4
    • 0034128936 scopus 로고    scopus 로고
    • Human UDP-glucuronosyl-transferases: Metabolism, expression, and disease
    • Tukey, R. H.; Strassburg, C. P. Human UDP-glucuronosyl-transferases: metabolism, expression, and disease. Annu. Rev.Pharmacol. Toxicol., 2000, 40, 581-616.
    • (2000) Annu. Rev.Pharmacol. Toxicol. , vol.40 , pp. 581-616
    • Tukey, R.H.1    Strassburg, C.P.2
  • 7
    • 0033661491 scopus 로고    scopus 로고
    • Tissue distribution and interindividual variation in human UDP-glucuronosyl-transferase activity: Relationship between UGT1A1 promoter geno-type and variability in a liver bank
    • Fisher, M. B.; Vandenbranden, M.; Findlay, K.; Burchell, B.; Thummel, K. E.; Hall, S. D.; Wrighton, S. A. Tissue distribution and interindividual variation in human UDP-glucuronosyl-transferase activity: relationship between UGT1A1 promoter geno-type and variability in a liver bank. Pharmacogenetics, 2000, 10(8), 727-739.
    • (2000) Pharmacogenetics , vol.10 , Issue.8 , pp. 727-739
    • Fisher, M.B.1    Vandenbranden, M.2    Findlay, K.3    Burchell, B.4    Thummel, K.E.5    Hall, S.D.6    Wrighton, S.A.7
  • 8
    • 0035209568 scopus 로고    scopus 로고
    • Therole of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism
    • Fisher, M. B.; Paine, M. F.; Strelevitz, T. J.; Wrighton, S. A. Therole of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism. Drug Metab. Rev., 2001, 33(3-4), 273-297.
    • (2001) Drug Metab. Rev. , vol.33 , Issue.3-4 , pp. 273-297
    • Fisher, M.B.1    Paine, M.F.2    Strelevitz, T.J.3    Wrighton, S.A.4
  • 9
    • 0032568310 scopus 로고    scopus 로고
    • Effect of troglitazone in insulin-treated patients with type II diabetes mellitus. Troglitazone and Exogenous Insulin Study Group
    • Schwartz, S.; Raskin, P.; Fonseca, V.; Graveline, J. F. Effect of troglitazone in insulin-treated patients with type II diabetes mellitus. Troglitazone and Exogenous Insulin Study Group. N. Engl. J. Med., 1998, 338(13), 861-866.
    • (1998) N. Engl. J. Med. , vol.338 , Issue.13 , pp. 861-866
    • Schwartz, S.1    Raskin, P.2    Fonseca, V.3    Graveline, J.F.4
  • 11
    • 0035879932 scopus 로고    scopus 로고
    • Troglitazone quinone formation catalyzed by human and rat CYP3A: An atypical CYP oxidation reaction
    • He, K.; Woolf, T. F.; Kindt, E. K.; Fielder, A. E.; Talaat, R. E. Troglitazone quinone formation catalyzed by human and rat CYP3A: an atypical CYP oxidation reaction. Biochem. Pharmacol., 2001, 62(2), 191-198.
    • (2001) Biochem. Pharmacol. , vol.62 , Issue.2 , pp. 191-198
    • He, K.1    Woolf, T.F.2    Kindt, E.K.3    Fielder, A.E.4    Talaat, R.E.5
  • 12
    • 23344450788 scopus 로고    scopus 로고
    • Induction of phase I, II and III drug metabolism/transport by xenobiotics
    • Xu, C.; Li, C. Y.; Kong, A. N. Induction of phase I, II and III drug metabolism/transport by xenobiotics. Arch. Pharm. Res., 2005, 28(3), 249-268.
    • (2005) Arch. Pharm. Res. , vol.28 , Issue.3 , pp. 249-268
    • Xu, C.1    Li, C.Y.2    Kong, A.N.3
  • 13
    • 23144464155 scopus 로고    scopus 로고
    • Xenobiotic nuclear receptor-mediated regulation of UDP-glucuronosyl-transferases
    • Zhou, J.; Zhang, J.; Xie, W. Xenobiotic nuclear receptor-mediated regulation of UDP-glucuronosyl-transferases. Curr. Drug Metab., 2005, 6(4), 289-298.
    • (2005) Curr. Drug Metab. , vol.6 , Issue.4 , pp. 289-298
    • Zhou, J.1    Zhang, J.2    Xie, W.3
  • 14
    • 34247349605 scopus 로고    scopus 로고
    • Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: Implications for interindividual variability in response to drugs
    • Urquhart, B. L.; Tirona, R. G.; Kim, R. B. Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: implications for interindividual variability in response to drugs. J. Clin. Pharmacol., 2007, 47(5), 566-578.
    • (2007) J. Clin. Pharmacol. , vol.47 , Issue.5 , pp. 566-578
    • Urquhart, B.L.1    Tirona, R.G.2    Kim, R.B.3
  • 15
    • 1042287037 scopus 로고    scopus 로고
    • The induction of human UDP-glucuronosyltransferase 1A1 mediated through a distal enhancer module by flavonoids and xenobiotics
    • Sugatani, J.; Yamakawa, K.; Tonda, E.; Nishitani, S.; Yoshinari, K.; Degawa, M.; Abe, I.; Noguchi, H.; Miwa, M. The induction of human UDP-glucuronosyltransferase 1A1 mediated through a distal enhancer module by flavonoids and xenobiotics. Biochem. Pharmacol., 2004, 67(5), 989-1000.
    • (2004) Biochem. Pharmacol. , vol.67 , Issue.5 , pp. 989-1000
    • Sugatani, J.1    Yamakawa, K.2    Tonda, E.3    Nishitani, S.4    Yoshinari, K.5    Degawa, M.6    Abe, I.7    Noguchi, H.8    Miwa, M.9
  • 16
    • 14944341677 scopus 로고    scopus 로고
    • Transcriptional regulation of human UGT1A1 gene expression: Activated glucocorticoid receptor enhances constitutive androstane receptor/pregnane X receptor-mediated UDP-glucuronosyltransferase 1A1 regulation with glucocorticoid receptor-interacting protein 1
    • Sugatani, J.; Nishitani, S.; Yamakawa, K.; Yoshinari, K.; Sueyoshi, T.; Negishi, M.; Miwa, M. Transcriptional regulation of human UGT1A1 gene expression: activated glucocorticoid receptor enhances constitutive androstane receptor/pregnane X receptor-mediated UDP-glucuronosyltransferase 1A1 regulation with glucocorticoid receptor-interacting protein 1. Mol. Pharmacol., 2005, 67(3), 845-855.
    • (2005) Mol. Pharmacol. , vol.67 , Issue.3 , pp. 845-855
    • Sugatani, J.1    Nishitani, S.2    Yamakawa, K.3    Yoshinari, K.4    Sueyoshi, T.5    Negishi, M.6    Miwa, M.7
  • 17
    • 17644364027 scopus 로고    scopus 로고
    • Modulation of UDP-glucuronosyltransferase 1A1 in primary human hepatocytes by prototypical inducers
    • Smith, C. M.; Faucette, S. R.; Wang, H.; LeCluyse, E. L. Modulation of UDP-glucuronosyltransferase 1A1 in primary human hepatocytes by prototypical inducers. J. Biochem. Mol. Toxicol., 2005, 19(2), 96-108.
    • (2005) J. Biochem. Mol. Toxicol. , vol.19 , Issue.2 , pp. 96-108
    • Smith, C.M.1    Faucette, S.R.2    Wang, H.3    Lecluyse, E.L.4
  • 18
    • 33749035441 scopus 로고    scopus 로고
    • Reporter gene Cellular Model for Evaluating Induction of CYP3A4 by New Chemical Entities
    • Enoru-Eta, J. Y.; L.G.; Kao, J.; Scatina, J. A.; Reporter gene Cellular Model for Evaluating Induction of CYP3A4 by New Chemical Entities. Drug Develop. Res., 2006, 67(5), 470-475.
    • (2006) Drug Develop. Res. , vol.67 , Issue.5 , pp. 470-475
    • Enoru-Eta, J.Y.1
  • 19
    • 0032791711 scopus 로고    scopus 로고
    • Expression and inducibility of the human bilirubin UDP-glucuronosyltransferase UGT1A1 in liver and cultured primary hepatocytes: Evidence for both genetic and environmental influences
    • Ritter, J. K.; Kessler, F. K.; Thompson, M. T.; Grove, A. D.; Auyeung, D. J.; Fisher, R. A. Expression and inducibility of the human bilirubin UDP-glucuronosyltransferase UGT1A1 in liver and cultured primary hepatocytes: evidence for both genetic and environmental influences. Hepatology, 1999, 30(2), 476-484.
    • (1999) Hepatology , vol.30 , Issue.2 , pp. 476-484
    • Ritter, J.K.1    Kessler, F.K.2    Thompson, M.T.3    Grove, A.D.4    Auyeung, D.J.5    Fisher, R.A.6
  • 20
    • 0030221217 scopus 로고    scopus 로고
    • The glucuronidation of exogenous and endogenous compounds by stably expressed rat and human UDP-glucuronosyltransferase 1.1
    • King, C. D.; Green, M. D.; Rios, G. R.; Coffman, B. L.; Owens, I. S.; Bishop, W. P.; Tephly, T. R. The glucuronidation of exogenous and endogenous compounds by stably expressed rat and human UDP-glucuronosyltransferase 1.1. Arch. Biochem. Biophys., 1996, 332(1), 92-100.
    • (1996) Arch. Biochem. Biophys. , vol.332 , Issue.1 , pp. 92-100
    • King, C.D.1    Green, M.D.2    Rios, G.R.3    Coffman, B.L.4    Owens, I.S.5    Bishop, W.P.6    Tephly, T.R.7
  • 21
    • 6944221357 scopus 로고    scopus 로고
    • Drug-drug in-teractions for UDP-glucuronosyltransferase substrates: A pharma-cokinetic explanation for typically observed low exposure (AUCi/AUC) ratios
    • Williams, J. A.; Hyland, R.; Jones, B. C.; Smith, D. A.; Hurst, S.; Goosen, T. C.; Peterkin, V.; Koup, J. R.; Ball, S. E. Drug-drug in-teractions for UDP-glucuronosyltransferase substrates: a pharma-cokinetic explanation for typically observed low exposure (AUCi/AUC) ratios. Drug Metab. Dispos., 2004, 32(11), 1201-1208.
    • (2004) Drug Metab. Dispos , vol.32 , Issue.11 , pp. 1201-1208
    • Williams, J.A.1    Hyland, R.2    Jones, B.C.3    Smith, D.A.4    Hurst, S.5    Goosen, T.C.6    Peterkin, V.7    Koup, J.R.8    Ball, S.E.9
  • 22
    • 1642579667 scopus 로고    scopus 로고
    • An assessment of udp-glucuronosyltransferase induction using primary human hepatocytes
    • Soars, M. G.; Petullo, D. M.; Eckstein, J. A.; Kasper, S. C.; Wrighton, S. A. An assessment of udp-glucuronosyltransferase induction using primary human hepatocytes. Drug Metab. Dispos., 2004, 32(1), 140-148.
    • (2004) Drug Metab. Dispos. , vol.32 , Issue.1 , pp. 140-148
    • Soars, M.G.1    Petullo, D.M.2    Eckstein, J.A.3    Kasper, S.C.4    Wrighton, S.A.5
  • 24
    • 0035029401 scopus 로고    scopus 로고
    • The phenobarbital response enhancer module in the human bilirubin UDP- glucuronosyltransferase UGT1A1 gene and regulation by the nuclear receptor CAR
    • Sugatani, J.; Kojima, H.; Ueda, A.; Kakizaki, S.; Yoshinari, K.; Gong, Q. H.; Owens, I. S.; Negishi, M.; Sueyoshi, T. The phenobarbital response enhancer module in the human bilirubin UDP- glucuronosyltransferase UGT1A1 gene and regulation by the nuclear receptor CAR. Hepatology, 2001, 33(5), 1232-1238.
    • (2001) Hepatology , vol.33 , Issue.5 , pp. 1232-1238
    • Sugatani, J.1    Kojima, H.2    Ueda, A.3    Kakizaki, S.4    Yoshinari, K.5    Gong, Q.H.6    Owens, I.S.7    Negishi, M.8    Sueyoshi, T.9
  • 25
    • 0038236664 scopus 로고    scopus 로고
    • Involvement of the xenobiotic response element (XRE) in Ah receptor-mediated induction of human UDP-glucuronosyltransferase 1A1
    • Yueh, M. F.; Huang, Y. H.; Hiller, A.; Chen, S.; Nguyen, N.; Tukey, R. H. Involvement of the xenobiotic response element (XRE) in Ah receptor-mediated induction of human UDP-glucuronosyltransferase 1A1. J. Biol. Chem., 2003, 278(17), 15001-15006.
    • (2003) J. Biol. Chem. , vol.278 , Issue.17 , pp. 15001-15006
    • Yueh, M.F.1    Huang, Y.H.2    Hiller, A.3    Chen, S.4    Nguyen, N.5    Tukey, R.H.6
  • 26
    • 34247631742 scopus 로고    scopus 로고
    • The evolving role of drug metabolism in drug discovery and development
    • Yengi, L. G.; Leung, L.; Kao, J. The evolving role of drug metabolism in drug discovery and development. Pharm. Res., 2007, 24(5), 842-858.
    • (2007) Pharm. Res. , vol.24 , Issue.5 , pp. 842-858
    • Yengi, L.G.1    Leung, L.2    Kao, J.3
  • 27
    • 33846410787 scopus 로고    scopus 로고
    • Nuclear receptor-mediated transcriptional regulation in Phase I, II, and III xenobiotic metabolizing systems
    • Nakata, K.; Tanaka, Y.; Nakano, T.; Adachi, T.; Tanaka, H.; Ka-minuma, T.; Ishikawa, T. Nuclear receptor-mediated transcriptional regulation in Phase I, II, and III xenobiotic metabolizing systems. Drug Metab. Pharmacokinet., 2006, 21(6), 437-457.
    • (2006) Drug Metab. Pharmacokinet. , vol.21 , Issue.6 , pp. 437-457
    • Nakata, K.1    Tanaka, Y.2    Nakano, T.3    Adachi, T.4    Tanaka, H.5    Ka-Minuma, T.6    Ishikawa, T.7
  • 31
    • 0030030762 scopus 로고    scopus 로고
    • Genetic variation in bilirubin UPD-glucuronosyltransferase gene promoter and Gilbert's syndrome
    • Monaghan, G.; Ryan, M.; Seddon, R.; Hume, R.; Burchell, B. Genetic variation in bilirubin UPD-glucuronosyltransferase gene promoter and Gilbert's syndrome. Lancet, 1996, 347(9001), 578-581.
    • (1996) Lancet , vol.347 , Issue.9001 , pp. 578-581
    • Monaghan, G.1    Ryan, M.2    Seddon, R.3    Hume, R.4    Burchell, B.5
  • 33
    • 0025218656 scopus 로고
    • Rifampin relieves pruritus in children with cholestatic liver disease
    • Cynamon, H. A.; Andres, J. M.; Iafrate, R. P. Rifampin relieves pruritus in children with cholestatic liver disease. Gastroenterology, 1990, 98(4), 1013-1016.
    • (1990) Gastroenterology , vol.98 , Issue.4 , pp. 1013-1016
    • Cynamon, H.A.1    Andres, J.M.2    Iafrate, R.P.3
  • 34
    • 0032172828 scopus 로고    scopus 로고
    • Unexpected clinical remission of cholestasis after rifampicin therapy in patients with normal or slightly increased levels of gammaglutamyl transpeptidase
    • Cancado, E. L.; Leitao, R. M.; Carrilho, F. J.; Laudanna, A. A. Unexpected clinical remission of cholestasis after rifampicin therapy in patients with normal or slightly increased levels of gammaglutamyl transpeptidase. Am. J. Gastroenterol., 1998, 93(9), 1510-1517.
    • (1998) Am. J. Gastroenterol. , vol.93 , Issue.9 , pp. 1510-1517
    • Cancado, E.L.1    Leitao, R.M.2    Carrilho, F.J.3    Laudanna, A.A.4
  • 35
    • 0021878377 scopus 로고
    • Effect of rifampicin treatment on hepatic drug metabolism and serum bile acids in patients with primary biliary cirrhosis
    • Hoensch, H. P.; Balzer, K.; Dylewizc, P.; Kirch, W.; Goebell, H.; Ohnhaus, E. E. Effect of rifampicin treatment on hepatic drug metabolism and serum bile acids in patients with primary biliary cirrhosis. Eur. J. Clin. Pharmacol., 1985, 28(4), 475-477.
    • (1985) Eur. J. Clin. Pharmacol. , vol.28 , Issue.4 , pp. 475-477
    • Hoensch, H.P.1    Balzer, K.2    Dylewizc, P.3    Kirch, W.4    Goebell, H.5    Ohnhaus, E.E.6
  • 36
    • 0034964158 scopus 로고    scopus 로고
    • Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation
    • LeCluyse, E. L. Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation. Eur. J. Pharm. Sci., 2001, 13(4), 343-368.
    • (2001) Eur. J. Pharm. Sci. , vol.13 , Issue.4 , pp. 343-368
    • Lecluyse, E.L.1
  • 37
    • 0035154160 scopus 로고    scopus 로고
    • Application of rat hepatocyte culture to predict in vivo metabolic auto-induction: Studies with DFP, a cyclooxygenase-2 inhibitor
    • Nicoll-Griffith, D. A.; Silva, J. M.; Chauret, N.; Day, S.; Leblanc, Y.; Roy, P.; Yergey, J. A.; Dixit, R.; Patrick, D. Application of rat hepatocyte culture to predict in vivo metabolic auto-induction: studies with DFP, a cyclooxygenase-2 inhibitor. Drug Metab. Dispos., 2001, 29(2), 159-165.
    • (2001) Drug Metab. Dispos. , vol.29 , Issue.2 , pp. 159-165
    • Nicoll-Griffith, D.A.1    Silva, J.M.2    Chauret, N.3    Day, S.4    Leblanc, Y.5    Roy, P.6    Yergey, J.A.7    Dixit, R.8    Patrick, D.9
  • 38
    • 0032968777 scopus 로고    scopus 로고
    • Cryopreserved human hepatocytes: Characterization of drug-metabolizing enzyme activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug-drug interaction potential
    • Li, A. P.; Lu, C.; Brent, J. A.; Pham, C.; Fackett, A.; Ruegg, C. E.; Silber, P. M. Cryopreserved human hepatocytes: characterization of drug-metabolizing enzyme activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug-drug interaction potential. Chem. Biol. Interact., 1999, 121(1), 17-35.
    • (1999) Chem. Biol. Interact. , vol.121 , Issue.1 , pp. 17-35
    • Li, A.P.1    Lu, C.2    Brent, J.A.3    Pham, C.4    Fackett, A.5    Ruegg, C.E.6    Silber, P.M.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.